Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
Bioss COVID-19 Products
The ultimate goal of Bioss is to improve the health and quality of life of humans and animals. To fight against COVID-19, Bioss has developed antibodies, proteins, and the ELISA kit in support of studies on the novel coronavirus.
Pennybody Promotion
Haven't worked with Bioss Antibodies before? Try one of our 20uL trial-sized vials for just $0.01 plus shipping. Click here to view program details and to request your discount code for this promotional pricing.
The Blog
Protective Antibodies Against COVID-19 Isolated & CharacterizedIn the search for interventions against COVID-19, one potential mode of intervention would be to block viral entry into target cells by blocking the interaction between the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 and the ACE2 receptor on human cells. Antibodies that can block viral entry into cells, thus neutralizing any effect the virus has biologically, are called neutralizing antibodies. Only a small subset of antibodies that bind a virus are capable of neutralization.
COVID-19 Antibody TestingThe first wave of Covid-19 tests is designed to determine whether you have the SARS-CoV-2 virus right now. As the world starts to eye an exit from lockdown, the second wave of tests is trying to find out if you had the virus in the past. To this end, COVID-19 antibody tests are on the rise throughout the U.S.
Newly discovered coronavirus mutations warn vaccine developersThe most aggressive strains of SARS-CoV-2 were able to generate 270 times the viral load as the weakest strains. The mutations could help explain why the virus seems to spread differently and cause varied severity of symptoms across different parts of the world.
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
About Us
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.